But pulmonary disease occur frequently after HSCT.
但HSCT术后肺部并发症时常发生。
The highly-effective preparative regimens of proper dose and low-toxicity are the key to the successful HSCT.
找出合理的剂量和新的高效低毒的预处理方案是提高造血干细胞移植成功率的关键。
Objective To explore the effective prevention of perianal infection following hemopoietic stem cell transplantation (HSCT).
目的探讨造血干细胞移植(HSCT)病人肛周感染的有效预防措施。
After hematopoietic stem cell transplantation (HSCT), early detection of engraftment would be of critical value for clinicians.
对于临床医生来说，造血干细胞移植(HSCT)后，早期检测移植存活是极其重要的。
Conclusion Sensitized donor lymphocytes infusion after HSCT evidently promoted the immune reconstitution and reduced the incidence of GVHD.
结论造血干细胞移植后输注致敏供者的淋巴细胞能促进受者的免疫功能重建，并可减少GVHD的发生。
Besides technological advances, choosing the most appropriate donor is also an important factor to overcome the HLA barriers in haploidentical HSCT.
为克服供受体h LA差异对半相合移植的不利影响，除改良移植技术之外，选择最为合适的供体也是决定手术成败的重要因素。
This represents a major advance for antifungal therapy in haematological malignancy patients undergoing chemotherapy or haematopoietic stem cell transplant (HSCT).
这是接受化疗或造血干细胞移植（HSCT）血液恶性肿瘤患者抗真菌治疗的重大进展。
Posaconazole has a broad spectrum of activity in vitro and a potentially key role in antifungal prophylaxis in high-risk HSCT recipients and during prolonged neutropenia.
泊沙康唑在体外具有广谱抗真菌活性，对于高危hsct受者以及持续中性粒细胞减少患者侵袭性真菌感染的预防可能有重要作用。
Severe aplastic anemia can be cured by haematopoietic stem cell transplantation. Synegenic HSCT is the best choice for severe aplastic anemia and chronic aplastic anemia.
造血干细胞移植是治愈重型再障的主要手段，同基因造血干细胞移植也适合慢性再障。
Invasive fungal infections (IFI) are a kind of the most severe complications after hematopoietic stem cell transplantation (HSCT), Candida and Aspergillus are common causes.
侵袭性真菌感染(ifi)是一种十分严重的造血干细胞移植(HSCT)并发症，以念珠菌属和曲霉菌属感染最常见。
Objectives To determine current use of HSCT to assess differences in its application and to explore associations of macroeconomic factors with transplant rates on a global level.
目的明确目前造血干细胞移植的开展情况，以评估其差异，并在全球水平上探讨与移植率相关的宏观经济因素。
Objective to investigate the clinicopathologic characteristics of renal chronic graft versus host disease (GVHD) after allogeneic peripheral blood hematopoietic transplantation (HSCT).
目的探讨异基因造血干细胞移植(HSCT)后表现在肾脏的慢性移植物抗宿主病(GVHD)的临床及病理特点。
Hematopoietic stem cell transplantation (HSCT) is performed for complete healing of hematologic disorders and as a supportive therapy after high-dose chemotherapy against malignant diseases.
造血干细胞移植(HSCT)常被用来治疗血液系统疾病和作为血液系统恶性疾病高剂量化疗后的支持治疗。
Hematopoietic stem cell transplantation (HSCT) is performed for complete healing of hematologic disorders and as a supportive therapy after high-dose chemotherapy against malignant diseases.
造血干细胞移植(HSCT)常被用来治疗血液系统疾病和作为血液系统恶性疾病高剂量化疗后的支持治疗。
应用推荐